BioSpace News Archive

Artificial Cornea Implant Market: Increasing cases of corneal eye disease across the globe to drive the market

The global artificial cornea implant market is likely to expand in the near future. This is mainly because of the increasing cases of corneal eye disease across the globe.

March 29, 2021
·
4 min read
Intravenous Solution Market: Increase in Demand for Intravenous Solutions to Drive the Market

Intravenous solutions are routinely used in clinical medicine for the replacement and maintenance of body fluids. They are administered to individuals with depletion of body fluids due to dehydration and other medical conditions.

March 29, 2021
·
5 min read
Retinal Drugs and Biologics Market: Increasing incidence of retinal disorder to drive the market

Human eyes are highly delicate and can be affected with the minutest of the things. Therefore, it security is of high importance.

March 29, 2021
·
4 min read
Fibromyalgia Market - North America Continues to Dominate the Market | TMR Research Study

Fibromyalgia also called Fibrositis, is a chronic pain disorder causing a widespread pain and tenderness to touch. Fibromyalgia affects people physically, mentally and socially.

March 29, 2021
·
7 min read
Plaquenil Drugs Market is expected to grow at a CAGR between 6-9% by 2031

Plaquenil drug, brand name of Hydroxychloroquine, is a disease modifying anti-rheumatic drug. It eases the pain and swelling of arthritis.

March 29, 2021
·
4 min read
Business

Jacobio Pharma Announces CNY486 Million Revenue for 2020 Annual Results

Jacobio Pharmaceuticals announces its first annual results after its IPO. Revenue was CNY486 million; R&D costs exceeded CNY230 million, increasing 66% year-on-year.

March 29, 2021
·
2 min read
Business

OKYO Pharma Limited (“OKYO” or the “Company”) - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer

OKYO, the life sciences and biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, announces that it has appointed Dr Rajkumar Patil as Chief Scientific Officer.

March 29, 2021
·
2 min read
Drug Development

HUTCHMED Initiates International Phase I Trials of IDH1/2 Dual Inhibitor in Patients with Advanced Solid Tumors or Hematological Malignancies

HMPL-306 is the sixth innovative oncology drug candidate discovered in house by HUTCHMED to enter into global development

March 29, 2021
·
7 min read
BioMidwest

Sun Nuclear Expands with New Facility in the Netherlands to Support Rapid Growth Throughout the EMEA Region

Sun Nuclear Corporation, a leader in independent Quality Management solutions for Radiation Therapy and Diagnostic Imaging, announced the opening of its new SunServices™ Center in Breda, the Netherlands.

March 29, 2021
·
2 min read
Policy

The PROTECT-V trial investigating UNIONs COVID-19 candidate receives Urgent Public Health Prioritization from the UK government

UNION therapeutics A/S announced that the National Institute for Health Research in the UK has granted Urgent Public Health prioritization to the PROTECT-V trial - a platform study investigating UNION’s niclosamide-based treatment candidate for COVID-19 in kidney patients.

March 29, 2021
·
2 min read